首页 正文

Prevention of hepatitis B virus reinfection in liver transplant recipients

{{output}}
Antiviral therapy using newer nucleos(t)ide analogues with lower resistance rates such as entecavir or tenofovir could suppress hepatitis B virus (HBV) replication, improve liver function, delay or obviate the need for liver transplantation in some patients, a... ...